AUS
NZ
UK
CA
USA
IND
Health
How Is Select Medical (NYSE:SEM) Navigating the Changing Healthcare Landscape?
March 13, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Institutional investors have increased their holdings in Select Medical, reflecting market activity.,Select Medical continues to maintain a consistent dividend policy.,The company operates across multiple healthcare segments, ensuring broa...
How Is Premier, Inc. (NASDAQ:PINC) Expanding Its Healthcare Solutions Business?
March 13, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Steward Partners Investment Advisory LLC acquired a position in Premier, Inc., increasing its holdings in the fourth quarter.,The company operates through Supply Chain Services and Performance Services, providing healthcare solutions acros...
Is Institutional Interest in CeriBell (NASDAQ:CRBL) Signaling Market Confidence?
March 13, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Institutional investors, including major financial firms, have increased their stakes in CeriBell.,The company continues to focus on expanding its EEG technology for neurological assessments.,Market performance reflects recent stock fluctu...
How Is Insulet Corporation (NASDAQ:PODD) Expanding Its Presence in Medical Technology?
March 13, 2025 12:00 AM PDT| By Team Kalkine MediaHighlights,Institutional investors are raising their stakes in Insulet Corporation, showing confidence in its business direction.,The company continues to innovate in insulin delivery technology, strengthening its market position.,Recent developments...
Avanos Medical: Latest Developments and Market Movements
March 12, 2025 11:26 PM PDT| By Team Kalkine MediaHighlights,Avanos Medical’s stock recently witnessed a shift in analyst ratings from "buy" to "hold".,Institutional investors are actively adjusting their stakes in Avanos Medical, with significant changes noted in the third quarter.,The company cont...
Lake Street Capital Releases Negative Outlook for Sensus Healthcare (NASDAQ:SRTS) Stock Price
March 12, 2025 11:26 PM PDT| By Team Kalkine MediaHighlights,Sensus Healthcare's stock target price has been adjusted with a suggestion of significant potential upside.,Institutional investors and hedge funds are actively adjusting their stakes in Sensus Healthcare.,Sensus Healthcare specializes in...
Jefferies Financial Group has reduced its projected stock price for Corbus Pharmaceuticals (NASDAQ:CRBP).
March 12, 2025 11:26 PM PDT| By Team Kalkine MediaHighlights,Equity research from Jefferies Financial Group and others have adjusted price targets and ratings for Corbus Pharmaceuticals (NASDAQ:CRBP) amid fluctuating market conditions.,Institutional investors are actively trading shares, with a nota...
uniQure's (NASDAQ:QURE) Strategic Developments and Market Trends
March 12, 2025 11:26 PM PDT| By Team Kalkine MediaHighlight,uniQure (QURE) has received varying ratings from analysts, reflecting diverse market sentiments.,The company's stock has shown significant fluctuation, with a current notable uptick.,Institutional investors exhibit continued interest, signa...
What Drives Attention to Zura Bio Limited Stock?
March 12, 2025 11:26 PM PDT| By Team Kalkine MediaHighlights,Innovative medicines for immune and inflammatory disorders are under development.,Institutional and hedge fund engagement marks notable participation.,Stock performance exhibits volatility amid ongoing clinical evaluations.,Zura Bio Limite...
Will ReWalk Robotics Reshape the Medical Device Arena?
March 12, 2025 11:26 PM PDT| By Team Kalkine MediaHighlights:,Lake Street Capital adjusted its price guidance for ReWalk Robotics (NASDAQ:LFWD) downward.,The company reported earnings below expectations with revenue slightly above forecasts.,Documented shifts in shareholder positions were recorded t...
Can Vertex Pharmaceuticals Sustain Its Biotech Leadership Amid Market Fluctuations?
March 12, 2025 11:26 PM PDT| By Team Kalkine MediaHighlights,Mixed evaluations have been observed among financial observers.,Executive share adjustments have occurred alongside ongoing institutional participation.,Vertex remains a central force in cystic fibrosis treatment with a robust market prese...
Can NeoGenomics Reinforce Its Position in Cancer Diagnostics?
March 12, 2025 11:25 PM PDT| By Team Kalkine MediaHighlights,Independent expert reviews have been largely positive with diverse professional viewpoints.,Financial results reflect a modest shortfall in earnings relative to consensus expectations amid active trading movements.,Institutional investors...
Could This Immunotherapy Innovator Transform the Biotech Landscape?
March 12, 2025 10:22 PM PDT| By Team Kalkine MediaHighlights,Receives more recognition from outside coverage,Shows fluctuations in share value over a defined range,Attracts involvement from various institutional entities,In the expanding biotechnology sector, immunotherapy has emerged as a central f...
Can NorthWest Healthcare REIT Redefine Global Healthcare Property Investments?
March 12, 2025 10:22 PM PDT| By Team Kalkine MediaHighlights:,National Bankshares has revised its outlook for NorthWest Healthcare Properties Real Estate Investment Trust (TSX:NWH.UN).,The trading range has spanned from its opening level to yearly extremes amid evolving market conditions.,The trust...
Can Market Momentum Transform INmune Bio's Future?
March 12, 2025 10:19 PM PDT| By Team Kalkine MediaHighlights,Multiple market research firms offer favorable evaluations.,Upward revisions in views have emerged from well‐known institutions.,Institutional participation in the stock has grown steadily.,INmune Bio, Inc. (NASDAQ:INMB) is positioned with...
Could 2seventy bio Transform Biotechnology?
March 12, 2025 10:19 PM PDT| By Team Kalkine MediaHighlights,Mixed market sentiment with diverse viewpoints observed.,Stock exhibited notable price fluctuations and active institutional engagement.,High concentration of institutional holdings and a focus on cell and gene therapy treatments.,2seventy...
Can Phathom Pharmaceuticals Redefine Biopharma Innovation?
March 12, 2025 10:18 PM PDT| By Team Kalkine MediaHighlights,Mixed professional viewpoints accompany Phathom Pharmaceuticals.,Company officials have adjusted their share positions.,Institutional investment activity remains robust.,In the biopharmaceutical field, companies address unmet medical needs...
Why Is Danaher Corporation’s Stock Showing Market Fluctuations?
March 12, 2025 09:44 PM PDT| By Team Kalkine MediaWhy Is Danaher Corporation’s Stock Showing Market Fluctuations?
Is CVS Health’s Business Strategy Strengthening Its Growth?
March 12, 2025 09:29 PM PDT| By Team Kalkine MediaIs CVS Health’s Business Strategy Strengthening Its Growth?
How Does Danaher Maintain Its Leadership In Biotechnology?
March 12, 2025 08:36 PM PDT| By Team Kalkine MediaHow Does Danaher Maintain Its Leadership in Biotechnology?
